Pancreas transplantation today: quo vadis?

Autor: Abdulrahman O Al-Naseem, Ahmed Attia, Ahmed Reda Gonnah, Abdulaziz O A S Al-Naseem, Harry V M Spiers, Angelika Gruessner, Lalantha Leelarathna, Hood Thabit, Titus Augustine

Publikováno v: Al-Naseem, A O, Attia, A, Gonnah, A R, Al-Naseem, A O A S, Spiers, H V M, Gruessner, A, Leelarathna, L, Thabit, H & Augustine, T 2023, ' Pancreas Transplantation Today: Quo Vadis? ', European Journal of Endocrinology, vol. 188, no. 4, pp. R73-R87 . https://doi.org/10.1093/ejendo/lvad032

Successful pancreas or islet transplantation is currently the only cure for type 1 diabetes mellitus. Since the first pancreas transplant in 1966, there have been various refinements of surgical technique along with improved immunosuppressive regimen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e01a3f43c00f12bfe2058ffdaad330d
https://doi.org/10.1093/ejendo/lvad032

Comparison of faster‐acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed‐loop insulin delivery

Autor: Hood Thabit, Womba Mubita, Jose Rubio, Mini Karuppan, Jonathan Schofield, Malgorzata E. Willinska, Roman Hovorka, Lalantha Leelarathna

Publikováno v: Thabit, H, Mubita, W, Rubio, J, Karuppan, M, Schofield, J, Willinska, M E, Hovorka, R & Leelarathna, L 2022, ' Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery ', Diabetes, Obesity and Metabolism . https://doi.org/10.1111/dom.14942

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e948f8f56cb8d1cdcbc4cc4c1041383d
https://doi.org/10.1111/dom.14942

Beware the pitfalls of time below range

Autor: Hood Thabit, Jonathan Schofield, Lalantha Leelarathna

Publikováno v: Diabetic Medicine.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2df62d86518053303ed20256f5a82fdd
https://doi.org/10.1111/dme.15124

The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective

Autor: Lalantha Leelarathna, Donna Ashley, Carrie Fidler, Witesh Parekh

Publikováno v: Therapeutic Advances in Endocrinology and Metabolism, Vol 9 (2018)

Background: Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. Th

Externí odkaz: https://doaj.org/article/24bd776b227548c4996161455354287d

Author response for 'CGM accuracy: Contrasting CE marking with the governmental controls of the USA ( FDA ) and Australia ( TGA ) – A narrative review'

Autor: null John S Pemberton, null Emma G Wilmot, null Katharine Barnard‐Kelly, null Lalantha Leelarathna, null Nick Oliver, null Tabitha Randell, null Craig E Taplin, null Pratik Choudhary, null Peter Adolfsson

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b044a1ed882f1353dd93b48416de1150
https://doi.org/10.1111/dom.14962/v2/response1